FDA approves first COVID-19 drug: the antiviral remdesivir
https://apnews.com/e03b6e713ad5e7b7ad74f23001a94f63
The U.S. Food and Drug Administration has approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given through an IV for patients needing hospitalization.
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.
